Advancing psychedelic research and therapies to benefit science, healthcare, and society since 2007.
Founded in 2007, the OPEN Foundation is the leading nonprofit organisation in the Netherlands and Europe dedicated to advancing the knowledge and understanding of psychedelics through research. We aim to optimise the potential of psychedelics in a therapeutic context and to help integrate psychedelics into society in a way that’s both sustainable and responsible. We fulfil our mission by bringing together and educating professionals, policymakers, and the public through conferences, trainings, membership programmes, and by facilitating and promoting rigorous, interdisciplinary research.
The Interdisciplinary Conference on Psychedelic Research (ICPR) is our scientific conference for academics, therapists, researchers, clinicians, policymakers, and members of the public. ICPR has been running since 2010 and we're gearing up for its 5th edition from September 22nd to 24th, 2022 in Amsterdam! ICPR continues to be the leading European conference dedicated to advancing psychedelic research and therapies. Already a ticket holder? Join our event platform below. In person tickets are sold out but livestream tickets are still available! Visit the ICPR website for more information.
Read the latest news from the OPEN Foundation and enjoy our educational blog series about advancing psychedelic research and therapies.
From touching talks to insightful perspectives, and profound new ways of thinking about reality to practical tips about doing therapy or research: ICPR 2022 has been an inspiring, thought-provoking, educational, and uplifting experience. Thanks to you all so much from the bottom of our hearts, whether you were a visitor, volunteer, speaker, presenter, digital visitor, or fan from afar: you made this conference what it was.
Wow, we’re already on the final day of ICPR 2022! We’ll hear from Roland Griffiths (virtually), trial participants, Rick Doblin, Gitte Moos Knudsen, Bernardo Kastrup and others on topics such as MDMA-assisted psychotherapy, indigenous medicine, business, microdosing, and critical perspectives on the quality of psychedelic research.
On day two of ICPR 2022, we’ll get the chance to hear from Bill Richards, David Nutt and Amanda Fielding and others on everything from palliative care and Deleuzian theory to cognition and perception, therapeutic models and cultural competency in psychedelic care.
We are ready for ICPR 2022! Three days of psychedelic science, on three stages, with more than 150 speakers and presenters. We’ve made an overview of the programme highlights so you can prep for the conference.
Bernardo Kastrup has been leading the modern renaissance of idealism, the notion that reality is essentially mental. What is idealism and how does it differ from materialism? And what role do psychedelics play?
Dr. Mendel Kaelen doesn’t believe the perfect playlist for psychedelic therapy exists. After ten years of research, Dr. Kaelen, Founder and CEO of Wavepaths, has developed an evidence-based, person-centered generative music product that allows the user and therapist to create a tailored music experience.
Wavepaths provides music both for and as psychedelic therapy, Mendel explained to the OPEN Foundation: “Music is a very powerful tool and I’m confident that we can view music as a psychedelic.”
We are extremely happy to be able to socialise with all of you soon at ICPR 2022. Yet we are fully aware of multiple ongoing crises right now. Out of care and concern for our living environment and other species, we decided to reduce ICPR’s ecological footprint per person compared to earlier conferences.
We have opted for vegetarian, mostly organic meals, have created a digital conference booklet instead of a printed one, and have dispatched with the tradition of physical swag bags…
For those coming to ICPR next month, we’d like to share what we have in store for you. We have our preliminary programme posted, and planned events, presentations and parties! Now that it seems our tickets sales are filling the Philharmonie in Haarlem to the rim, we’d like to take you on a preview of the week of ICPR.
In this post, the the full conference programme, the events surrounding the conference, the most important themes at this year’s conference, and… info about the afterparty!.
Our final speaker for ICPR 2022 has been confirmed! It is none other than Dr. Michael Bogenschutz, who is a professor of Psychiatry at NYU Grossman School of Medicine and Director of the NYU Langone Center for Psychedelic Medicine. Dr. Bogenschutz is well known for launching the first contemporary study of psilocybin-assisted psychotherapy for alcohol use disorder in 2015. He has published extensively on the topic of addiction and the therapeutic potential of psychedelics.
It’s a close cousin of DMT and knocked out boxer Mike Tyson enough to change his life around: 5-MeO-DMT. The psychedelic substance has become the topic of new scientific research that will also feature at ICPR. “It has the apparent ability to induce states of ego dissolution in a reliable fashion”, says one researcher studying its potential for psychedelic therapy.
Research and public interest in the therapeutic applications of psychedelics have been steadily increasing, with some calling it the mental health revolution we have all
OPEN’s Executive Director, Joost Breeksema, joined David Drapkin on episode 340 of the podcast of Psychedelics Today – one of ICPR’s platinum partners. Joost and
Read our full archive to see the stories we've shared.
Subscribe to our new OPEN-Minded newsletter to stay in the loop, hear about our events, and become part of a community dedicated to advancing psychedelics.
By clicking subscribe, I confirm to receive emails from the OPEN Foundation and agree with its privacy policy.
The OPEN Foundation regularly organises lectures, expert meetings, trainings, webinar series, symposiums, journal clubs, along with its biennial Interdisciplinary Conference on Psychedelic Research (ICPR). All the OPEN Foundation’s events focus on a rigorous, interdisciplinary approach to science. ICPR continues to be one of the largest European conferences dedicated to advancing psychedelic research and therapies.
The Interdisciplinary Conference on Psychedelic Research (ICPR) is a scientific conference for academics, therapists, researchers, clinicians, policymakers, and members of the public. ICPR features many of the world’s leading experts in psychedelic research and therapies from across many fields, including psychiatry, neuroscience, psychology, and anthropology. ICPR started in 2010 and its 5th edition will be in September 2022!
Organising scientific conferences, workshops, symposiums, journal clubs, master classes, and other educational events.
Facilitating and promoting rigorous, interdisciplinary research into psychedelics and their therapeutic applications.
Educating professionals through continued (medical) education trainings, practice-oriented workshops, and master classes.
Building communities and creating networking opportunities for researchers, therapists, and others interested in psychedelics.
Advocating for the safe, ethical, and sustainable development and integration of beneficial applications of psychedelics.
To advance psychedelic research and therapies, OPEN collaborates with the world's leading experts and organisations to offer the best events, programmes, and resources.
The OPEN Foundation’s events are centred around educating and connecting the key stakeholders in the psychedelic space.
The OPEN Foundation’s programmes include memberships, trainings, and research that attract both professionals and the public.
The OPEN Foundation’s resources are full of interesting content, including video talks from our previous conferences, research papers, book reviews, and more.
There are many ways we can work together to ensure that advancements in psychedelic research and therapies benefit science, healthcare, and society as a whole.
As an independent, nonprofit organisation, the OPEN Foundation applies an interdisciplinary and scientifically rigorous approach to the field of psychedelic research. We seek to, among other things:
OPEN facilitates and promotes rigorous scientific research into psychedelics and psychedelic-assisted therapies so we can better understand their benefits and risks.
OPEN collaborates with researchers, clinicians, and therapists, as well as with the mental health patients who could receive these treatments when approved.
OPEN connects and educates professionals, policymakers, and members of the public to help ensure that psychedelics are sustainably and responsibly integrated into society.
